8 Years’ experience with robotic thymectomy for thymomas

Keijzers, Marlies; Dingemans, Anne‐Marie C.; Blaauwgeers, Hans; Suylen, Robert Jan van; Hochstenbag, Monique; Garsse, Leen van; Accord, Ryan E.; Baets, M. de

doi:10.1007/s00464-013-3309-5

Cited by 38 publications

(18 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The multi-institutional European study by Marulli and colleagues [11] included patients with robotic resection of thymomas up to 10 cm in size. Keijzers and colleagues [10] reported a series of 37 patients with thymomas with median tumor size of 5.1 cm, which included 4 patients (11%) with advanced stage III/IVa disease. At our institution, we have not used tumor size as an absolute limiting factor for robotic approach.…”

Section: Commentmentioning

confidence: 99%

See 1 more Smart Citation

Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison

Kneuertz

Kamel

Stiles

et al. 2017

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

show abstract

Section: Commentmentioning

confidence: 99%

“…Over the past decade, the RAT approach has been offered to patients with large thymomas [10][11][12]. However, there has been a paucity of data.…”

mentioning

confidence: 99%

Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison

Kneuertz

Kamel

Stiles

et al. 2017

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

show abstract

“…Long-term results after thymectomy for early-stage thymoma have also been excellent, with a 5-year survival rate of 90%, though longer-term data with regards to survival and recurrence (a relevant consideration in this fairly indolent disease) remains unknown (10). Robotic thymectomy in pediatric patients and in patients with larger tumors and tumors involving lung, pericardium, and phrenic nerve have also been performed safely (11,12). We view invasion into the mediastinal vessels as the only indication for routine conversion (or initial approach via sternotomy, if obvious).…”

Section: Resultsmentioning

confidence: 99%

Robotic thymectomy

Wei¹,

Cerfolio²

2016

J. Vis. Surg.

View full text Add to dashboard Cite

Robotic thymectomy is an increasingly used modality. Patients who are candidates for traditional, open thymectomy are typically also candidates for robotic thymectomy, with the exception of patients with invasion of great vessels. Knowledge of and training on the robotic platform is critical for success. Patient and port positioning is described. Critical steps during robotic thymectomy include attention to careful division of the thymus off the innominate vein, and complete retrieval of bilateral superior horns of the gland. Robotic thymectomy may be performed with excellent perioperative and long-term outcomes for both neoplastic and non-neoplastic indications.

show abstract

“…lower rates of improvement of MG has not been confirmed in technically perfect thoracoscopic thymectomies [41][42][43][44][45]. Nowadays thymectomy can be performed on Masaoka-Koga stages I and II using minimally-invasive techniques [41][42][43].…”

Section: E128mentioning

confidence: 99%

Thymectomy in Myasthenia Gravis

Rückert

Swierzy

Köhler

et al. 2018

Neurology International Open

View full text Add to dashboard Cite

In recent years much progress has been made in the investigation of the pathophysiology, characterizing subgroups, and extension of multimodal treatment of myasthenia gravis (MG). This applies especially to the role of thymectomy (Thx). Thymectomy is always indicated for thymoma-associated myasthenia gravis. Furthermore, based on large cohort studies, during recent decades thymectomy has also become a central part of immune-modulating MG therapy in patients without thymoma. The lack of randomized studies, however, caused a certain persistent reluctance as to the significance of thymectomy. The current MGTX trial has shown the effectiveness of thymectomy. A significant improvement of myasthenic complaints and the reduction of immunosuppressive medication was primarily shown for acquired early-onset MG (EOMG) with complete resection of all thymic tissue. Because the MGTX study only included patients younger than 65 years with generalized MG and positive for acetylcholine-receptor antibodies, at present the significance of Thx for other relevant subgroups as juvenile MG, MG in older patients, ocular MG, as well as seronegative patients is under investigation. Even the prevailing opinion of no benefit of thymectomy for MuSk-positive patients probably needs reevaluation based on ambiguous findings. With respect to surgery, based on the exclusive performance of extended median sternotomy for MG in the MGTX, the value of thoracoscopic modifications for thymectomy as a minimally-invasive alternative is currently under evaluation. For clinical reasons further judgment regarding different minimally-invasive thymectomy techniques compared to the conventional open procedures in the form of randomized comparative studies would be required. Currently, however, an experience-based robotic-assisted thoracoscopic unilateral approach to thymectomy meets all requirements related to surgical, clinical-neurological and patient aspects. Ethical reasons, therefore, will lead to other strategies for comparison of different surgical techniques.

show abstract

8 Years’ experience with robotic thymectomy for thymomas

Abstract: Robotic thymectomies are safe in patients with early-stage thymomas. Robotic surgery may also be feasible for some selected advanced thymomas.

Cited by 38 publications

References 23 publications

Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison

Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison

Robotic thymectomy

Thymectomy in Myasthenia Gravis

Contact Info

Product

Resources

About